Nkcfo LLC Purchases New Position in DENTSPLY SIRONA Inc (NASDAQ:XRAY)

Nkcfo LLC purchased a new stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 5,200 shares of the medical instruments supplier’s stock, valued at approximately $303,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Robecosam AG grew its position in DENTSPLY SIRONA by 5.7% in the 2nd quarter. Robecosam AG now owns 459,611 shares of the medical instruments supplier’s stock worth $26,487,000 after purchasing an additional 24,661 shares during the period. Janus Henderson Group PLC grew its position in DENTSPLY SIRONA by 199.2% in the 2nd quarter. Janus Henderson Group PLC now owns 625,846 shares of the medical instruments supplier’s stock worth $36,524,000 after purchasing an additional 416,660 shares during the period. Municipal Employees Retirement System of Michigan grew its position in DENTSPLY SIRONA by 8.4% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 3,240 shares of the medical instruments supplier’s stock worth $189,000 after purchasing an additional 250 shares during the period. Aperio Group LLC grew its position in DENTSPLY SIRONA by 4.4% in the 2nd quarter. Aperio Group LLC now owns 155,059 shares of the medical instruments supplier’s stock worth $9,049,000 after purchasing an additional 6,512 shares during the period. Finally, AGF Investments LLC grew its position in DENTSPLY SIRONA by 15.9% in the 2nd quarter. AGF Investments LLC now owns 5,580 shares of the medical instruments supplier’s stock worth $326,000 after purchasing an additional 764 shares during the period. 97.06% of the stock is owned by institutional investors.

XRAY has been the subject of a number of recent research reports. HC Wainwright reissued a “neutral” rating and set a $57.00 price objective (up previously from $55.00) on shares of DENTSPLY SIRONA in a research report on Tuesday, July 9th. Wellington Shields raised shares of DENTSPLY SIRONA from a “hold” rating to a “gradually accumulate” rating in a research report on Friday, August 2nd. Evercore ISI initiated coverage on shares of DENTSPLY SIRONA in a research report on Friday, July 26th. They set an “in-line” rating for the company. Barrington Research reissued a “buy” rating and set a $63.00 price objective on shares of DENTSPLY SIRONA in a research report on Monday, August 5th. Finally, Guggenheim initiated coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, April 17th. They set a “neutral” rating and a $54.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have given a buy rating to the company. DENTSPLY SIRONA has a consensus rating of “Hold” and a consensus price target of $54.57.

In other DENTSPLY SIRONA news, SVP Markus Boehringer sold 22,900 shares of the business’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $54.80, for a total value of $1,254,920.00. Following the sale, the senior vice president now owns 49,849 shares in the company, valued at approximately $2,731,725.20. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Maureen J. Macinnis sold 15,000 shares of the business’s stock in a transaction on Monday, June 10th. The stock was sold at an average price of $56.06, for a total transaction of $840,900.00. Following the completion of the sale, the senior vice president now owns 25,360 shares in the company, valued at approximately $1,421,681.60. The disclosure for this sale can be found here. In the last 90 days, insiders have purchased 22,720 shares of company stock worth $1,223,243. 0.62% of the stock is owned by corporate insiders.

Shares of XRAY traded up $1.08 during trading hours on Tuesday, reaching $53.36. 96,617 shares of the stock traded hands, compared to its average volume of 1,857,033. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.39 and a current ratio of 2.08. DENTSPLY SIRONA Inc has a 52-week low of $33.93 and a 52-week high of $59.40. The company’s 50-day simple moving average is $55.98. The company has a market capitalization of $11.74 billion, a P/E ratio of 26.50, a P/E/G ratio of 1.91 and a beta of 0.97.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Friday, August 2nd. The medical instruments supplier reported $0.66 earnings per share for the quarter, beating analysts’ consensus estimates of $0.62 by $0.04. DENTSPLY SIRONA had a net margin of 2.67% and a return on equity of 9.19%. The company had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1.04 billion. During the same quarter in the previous year, the company earned $0.60 EPS. DENTSPLY SIRONA’s revenue for the quarter was down 3.1% on a year-over-year basis. Equities research analysts expect that DENTSPLY SIRONA Inc will post 2.39 earnings per share for the current fiscal year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: What is meant by a buy rating?

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.